Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model.
BACKGROUND: Cilostazol(CLZ) has been used as a vasodilating anti-platelet drug clinically and demonstrated to inhibit proliferation of smooth muscle cells and effect on endothelial cells. However, the effect of CLZ on re-endothelialization including bone marrow (BM)-derived endothelial progenitor ce...
Main Authors: | Rie Kawabe-Yako, Masaaki Ii, Osamu Masuo, Takayuki Asahara, Toru Itakura |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3171459?pdf=render |
Similar Items
-
Correction: Cilostazol Activates Function of Bone Marrow-Derived Endothelial Progenitor Cell for Re-endothelialization in a Carotid Balloon Injury Model
by: Rie Kawabe-Yako, et al.
Published: (2012-01-01) -
Correction: Cilostazol Activates Function of Bone Marrow-Derived Endothelial Progenitor Cell for Re-endothelialization in a Carotid Balloon Injury Model.
by: Rie Kawabe-Yako, et al.
Published: (2012-01-01) -
Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells.
by: Haruki Sekiguchi, et al.
Published: (2011-01-01) -
CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow.
by: Junjie Yang, et al.
Published: (2011-01-01) -
Bone Marrow-Derived Endothelial Progenitor Cells Reduce Recurrent Miscarriage in Gestation
by: Kazuyoshi Kanki1, et al.
Published: (2016-12-01)